Deferred Income Tax Expense (Benefit) of Tvardi Therapeutics, Inc. from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Tvardi Therapeutics, Inc. quarterly and annual Deferred Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • Tvardi Therapeutics, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $0.
  • Tvardi Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2018 was $0.
  • Tvardi Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2017 was $0.
  • Tvardi Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2016 was $0.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), Annual (USD)

Tvardi Therapeutics, Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 $0 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $0 $0 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q3 2024 $0 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $0 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2

Tvardi Therapeutics, Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2018 $0 $0 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2019 2018 FY
2017 $0 $0 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2019 2018 FY
2016 $0 $0 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019 2018 FY
2015 $0 $0 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2018 2017 FY
2014 $0 $0 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017 2016 FY
2013 $0 $0 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016 2015 FY
2012 $0 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.